FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1434879594> ?p ?o ?g. }

• W1434879594 endingPage "e0132298" @default.
• W1434879594 startingPage "e0132298" @default.
• W1434879594 abstract "To evaluate the clinical role of adjuvant chemotherapy (AC) in FIGO stage IB-IIA cervical cancer patients.A cohort of 262 patients with cervical cancer who received radical hysterectomy (RH) and adjuvant therapy at Asan Medical Center between 1992 and 2012 was enrolled. In this cohort, 85 patients received adjuvant chemotherapy (AC), and 177 received adjuvant radiotherapy or concurrent chemoradiation therapy (AR). Oncologic outcomes and adverse events in both treatment arms were compared using weighted Cox proportional hazards regression models with inverse-probability-of-treatment weighting (IPTW) to reduce the impact of treatment selection bias and potential confounding factors.During a 46.8-month median follow-up duration, 39 patients (14.9%) had recurrences, and 18 patients (6.9%) died of disease. In multivariate analysis, the hazard ratio (HR) for recurrence and death was not significantly different in patients in either treatment arm (p=0.62 and 0.12, respectively). Also, after IPTW matching, the HR for recurrence did not significantly differ between the arms (HR 1.57, 95% CI 0.68-3.62, p=0.29). Similarly, disease-free survival and overall survival were not significantly different between the arms (p=0.47 and 0.13, respectively). In addition, patients with AC had a much lower prevalence of long-term complications (lymphedema: n=8 (9.4%) vs. 46 (26.0%), p=0.03; ureteral stricture: n=0 vs. 9 (6.2%), p=0.05).Patients with FIGO stage IB-IIA cervical cancer can benefit from AC after RH with fewer long-term complications and non-inferior therapeutic effect to AR. Chemotherapy may therefore be an alternative adjuvant treatment option for cervical cancer, particularly in younger patients." @default.
• W1434879594 created "2016-06-24" @default.
• W1434879594 creator A5001632450 @default.
• W1434879594 creator A5018052527 @default.
• W1434879594 creator A5020638098 @default.
• W1434879594 creator A5020688996 @default.
• W1434879594 creator A5022424264 @default.
• W1434879594 creator A5053719602 @default.
• W1434879594 creator A5059132565 @default.
• W1434879594 creator A5061378632 @default.
• W1434879594 creator A5074590699 @default.
• W1434879594 date "2015-07-15" @default.
• W1434879594 modified "2023-09-27" @default.
• W1434879594 title "Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting" @default.
• W1434879594 cites W1585134448 @default.
• W1434879594 cites W1964961970 @default.
• W1434879594 cites W1965260240 @default.
• W1434879594 cites W1967933229 @default.
• W1434879594 cites W1988676348 @default.
• W1434879594 cites W1998898748 @default.
• W1434879594 cites W2003280499 @default.
• W1434879594 cites W2009758919 @default.
• W1434879594 cites W2016982738 @default.
• W1434879594 cites W2018458349 @default.
• W1434879594 cites W2018580495 @default.
• W1434879594 cites W2034943935 @default.
• W1434879594 cites W2036193982 @default.
• W1434879594 cites W2052020305 @default.
• W1434879594 cites W2070789376 @default.
• W1434879594 cites W2090996591 @default.
• W1434879594 cites W2106787323 @default.
• W1434879594 cites W2112121466 @default.
• W1434879594 cites W2123297927 @default.
• W1434879594 cites W2136352897 @default.
• W1434879594 cites W2148268093 @default.
• W1434879594 cites W2157719711 @default.
• W1434879594 cites W53340744 @default.
• W1434879594 doi "https://doi.org/10.1371/journal.pone.0132298" @default.
• W1434879594 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4503636" @default.
• W1434879594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26176626" @default.
• W1434879594 hasPublicationYear "2015" @default.
• W1434879594 type Work @default.
• W1434879594 sameAs 1434879594 @default.
• W1434879594 citedByCount "13" @default.
• W1434879594 countsByYear W14348795942016 @default.
• W1434879594 countsByYear W14348795942017 @default.
• W1434879594 countsByYear W14348795942018 @default.
• W1434879594 countsByYear W14348795942019 @default.
• W1434879594 countsByYear W14348795942020 @default.
• W1434879594 countsByYear W14348795942021 @default.
• W1434879594 countsByYear W14348795942022 @default.
• W1434879594 crossrefType "journal-article" @default.
• W1434879594 hasAuthorship W1434879594A5001632450 @default.
• W1434879594 hasAuthorship W1434879594A5018052527 @default.
• W1434879594 hasAuthorship W1434879594A5020638098 @default.
• W1434879594 hasAuthorship W1434879594A5020688996 @default.
• W1434879594 hasAuthorship W1434879594A5022424264 @default.
• W1434879594 hasAuthorship W1434879594A5053719602 @default.
• W1434879594 hasAuthorship W1434879594A5059132565 @default.
• W1434879594 hasAuthorship W1434879594A5061378632 @default.
• W1434879594 hasAuthorship W1434879594A5074590699 @default.
• W1434879594 hasBestOaLocation W14348795941 @default.
• W1434879594 hasConcept C121608353 @default.
• W1434879594 hasConcept C126322002 @default.
• W1434879594 hasConcept C126894567 @default.
• W1434879594 hasConcept C141071460 @default.
• W1434879594 hasConcept C143998085 @default.
• W1434879594 hasConcept C146357865 @default.
• W1434879594 hasConcept C151730666 @default.
• W1434879594 hasConcept C207103383 @default.
• W1434879594 hasConcept C2777863537 @default.
• W1434879594 hasConcept C2777982462 @default.
• W1434879594 hasConcept C2778220009 @default.
• W1434879594 hasConcept C2779494336 @default.
• W1434879594 hasConcept C2910227796 @default.
• W1434879594 hasConcept C44249647 @default.
• W1434879594 hasConcept C50382708 @default.
• W1434879594 hasConcept C509974204 @default.
• W1434879594 hasConcept C71924100 @default.
• W1434879594 hasConcept C72563966 @default.
• W1434879594 hasConcept C86803240 @default.
• W1434879594 hasConceptScore W1434879594C121608353 @default.
• W1434879594 hasConceptScore W1434879594C126322002 @default.
• W1434879594 hasConceptScore W1434879594C126894567 @default.
• W1434879594 hasConceptScore W1434879594C141071460 @default.
• W1434879594 hasConceptScore W1434879594C143998085 @default.
• W1434879594 hasConceptScore W1434879594C146357865 @default.
• W1434879594 hasConceptScore W1434879594C151730666 @default.
• W1434879594 hasConceptScore W1434879594C207103383 @default.
• W1434879594 hasConceptScore W1434879594C2777863537 @default.
• W1434879594 hasConceptScore W1434879594C2777982462 @default.
• W1434879594 hasConceptScore W1434879594C2778220009 @default.
• W1434879594 hasConceptScore W1434879594C2779494336 @default.
• W1434879594 hasConceptScore W1434879594C2910227796 @default.
• W1434879594 hasConceptScore W1434879594C44249647 @default.
• W1434879594 hasConceptScore W1434879594C50382708 @default.
• W1434879594 hasConceptScore W1434879594C509974204 @default.
• W1434879594 hasConceptScore W1434879594C71924100 @default.

• next